E-MAIL UPDATES

Click here to join
our Electronic Communications.

Click here to view our presentations at SITC 33rd Annual Meeting SITC 2018

Investors & Media

Whats new.

Press releases

Press releases.

Immutep Enters into Clinical Trial Collaboration, Service and Supply Agreement with Cytlimic

January 7th 2019
press releases

Immutep Announces US$5.2 Million Financing Led by U.S. Specialist Healthcare Investor, Altium Capital

December 19th 2018
press releases

Immutep Secures European Patent for Eftilagimod Alpha in Combination with Therapeutic Antibodies for Treating Cancer

November 29th 2018
press releases
more

Investor updates

Investor updates.

Investor Update - June 2018

June 19th 2018
investor updates

Investor Update - December 2017

December 21st 2017
investor updates

Investor Update Edition 21

October 1st 2017
investor updates
more

Analyst reports

Analyst reports.

Maxim - More TACTI-mel Data Presented at the Annual ICI Europe Summit

November 27th 2018
analyst reports

Edison - A big year ahead for efti

November 21st 2018
analyst reports

Maxim – Immutep Presents “efti” (LAG-3) Data at SITC Summary

November 13th 2018
analyst reports
more